Budget 2026: Pharma shares rise as FM proposes Bio Pharma Shakti scheme worth Rs 10,000 crore
Budget 2026: The BSE Healthcare index rose 370 pts to 41,717 in late morning deals against the previous close of 41,347.
- Feb 1, 2026,
- Updated Feb 1, 2026 11:33 AM IST
Pharma shares were trading higher on Sunday after Finance Minister Nirmala Sitharaman in her Budget speech said the government would unveil as a Bio Pharma Shakti scheme with an outlay of Rs 10,000 crore over five years. The objective of the scheme is to support domestic innovation, research, and development (R&D) in biopharmaceuticals, specifically targeting treatments for diabetes, cancer, and auto-immune issues.
The BSE Healthcare index rose 370 pts to 41,717 in late morning deals against the previous close of 41,347.
Sun Pharma Advanced Research Co Ltd (SPARC) shares rose 10%, Syncom Formulations (India) Ltd (10%), Shilpa Medicare (14%) were among the top gainers on the BSE pharma index.
Pharma shares were trading higher on Sunday after Finance Minister Nirmala Sitharaman in her Budget speech said the government would unveil as a Bio Pharma Shakti scheme with an outlay of Rs 10,000 crore over five years. The objective of the scheme is to support domestic innovation, research, and development (R&D) in biopharmaceuticals, specifically targeting treatments for diabetes, cancer, and auto-immune issues.
The BSE Healthcare index rose 370 pts to 41,717 in late morning deals against the previous close of 41,347.
Sun Pharma Advanced Research Co Ltd (SPARC) shares rose 10%, Syncom Formulations (India) Ltd (10%), Shilpa Medicare (14%) were among the top gainers on the BSE pharma index.